文献速递妇科产科

微创手术在卵巢癌治疗中的作用:系统综述与荟萃分析

The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · J Minim Invasive Gynecol · 2020-11-14

荟萃分析显示,微创与开腹手术在死亡或复发风险及全因死亡率上无显著差异,但多数研究为观察性设计且存在高偏倚风险,结论需谨慎解读。

要点

  • 微创与开腹手术在卵巢癌死亡或复发风险上无显著差异(合并HR 0.92,95%CI 0.61-1.38)。
  • 微创与开腹手术在全因死亡率上无显著差异(合并HR 0.96,95%CI 0.49-1.89)。
  • 一项随机试验显示诊断性腹腔镜可分流患者至新辅助化疗,避免不理想初次手术,不影响生存。

核心结论

  • 现有研究未显示卵巢癌微创手术对生存有不利影响,但文献方法学缺陷显著,数据需谨慎看待。

研究设计与样本

  • 纳入研究涉及分期(10项)、间隔减瘤(4项)、二次减瘤(2项)和可切除性评估(1项)。

主要发现

  • 微创与开腹手术与死亡或复发风险无显著关联(合并HR 0.92;95%CI 0.61-1.38)。
  • 微创与开腹手术与全因死亡率无显著关联(合并HR 0.96;95%CI 0.49-1.89)。
  • 一项随机试验表明诊断性腹腔镜可分流患者至新辅助化疗,避免不理想初次手术,不影响无复发生存或总生存。

关键数值与推荐

  • 合并 hazard ratio 0.92(95%CI 0.61-1.38)对应死亡或复发风险。
  • 合并 hazard ratio 0.96(95%CI 0.49-1.89)对应全因死亡率。

临床怎么用

  • 临床决策时可参考现有证据,微创手术未显示生存劣势,但需结合患者具体情况谨慎选择。
  • 诊断性腹腔镜可用于评估可切除性并分流患者至新辅助化疗,避免不理想初次手术。

局限性

  • 多数纳入研究为观察性设计,存在高偏倚风险。
  • 较少研究校正潜在混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To synthesize evidence from studies investigating survival outcomes for patients with ovarian cancer undergoing minimally invasive surgery (traditional or robotic laparoscopy) compared with those for patients with ovarian cancer undergoing laparotomy. DATA SOURCES: We searched Ovid MEDLINE and Embase (from inception to December 2019). METHODS OF STUDY SELECTION: Observational cohort studies and randomized controlled trials that compared risk of recurrence or death between women undergoing minimally invasive and open procedures for staging (10), interval cytoreduction (4), secondary cytoreduction (2), and evaluation of resectability (1) were included. TABULATION, INTEGRATION, AND RESULTS: Data on the number of participants, number of deaths and recurrences, and results of analyses of overall or progression-free survival were abstracted for all studies. A random-effects meta-analysis was used to pool the results of studies comparing minimally invasive staging and open staging. The surgical approach (minimally invasive versus open) was not significantly associated with hazard of death or recurrence (pooled hazard ratio 0.92; 95% confidence interval, 0.61-1.38) or all-cause mortality (pooled hazard ratio 0.96; 95% confidence interval, 0.49-1.89). One randomized trial demonstrated that diagnostic laparoscopy could triage patients to neoadjuvant chemotherapy and avoid suboptimal primary surgery, without affecting recurrence-free or overall survival. Most studies included in this review were observational and at high risk for bias, and few studies accounted for potential confounding. CONCLUSION: Although existing studies do not demonstrate deleterious survival effects associated with minimally invasive surgery for ovarian cancer, these data must be viewed with caution given the significant methodologic shortcomings in the existing literature.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Knisely A, Gamble CR, St Clair CM, et al. The Role of Minimally Invasive Surgery in the Care of Women with Ovarian Cancer: A Systematic Review and Meta-analysis. J Minim Invasive Gynecol. 2020. PMID: 33202311. doi:10.1016/j.jmig.2020.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。